Seguir
Patricia Soblechero Martin
Patricia Soblechero Martin
Biocruces Bizkaia Health Research Institute
Dirección de correo verificada de osakidetza.eus
Título
Citado por
Citado por
Año
An overview of alternative splicing defects implicated in myotonic dystrophy type I
A López-Martínez, P Soblechero-Martín, L de-la-Puente-Ovejero, ...
Genes 11 (9), 1109, 2020
802020
MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro
C Cerutti, P Soblechero-Martin, D Wu, MA Lopez-Ramirez, H de Vries, ...
Fluids and Barriers of the CNS 13, 1-7, 2016
382016
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
P Soblechero‐Martín, A López‐Martínez, L de la Puente‐Ovejero, ...
Neuropathology and Applied Neurobiology 47 (6), 711-723, 2021
292021
Metabolic syndrome contributes to renal injury mediated by hyperoxaluria in a murine model of nephrolithiasis
J Sáenz-Medina, E Jorge, C Corbacho, M Santos, A Sánchez, ...
Urolithiasis 46, 179-186, 2018
142018
Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening
P Soblechero-Martín, E Albiasu-Arteta, A Anton-Martinez, ...
Scientific Reports 11 (1), 18188, 2021
102021
miR-106b is a novel target to promote muscle regeneration and restore satellite stem cell function in injured Duchenne dystrophic muscle
L Rodriguez-Outeiriño, F Hernandez-Torres, FR de Acuña, A Rastrojo, ...
Molecular Therapy-Nucleic Acids 29, 769-786, 2022
42022
Evaluation of exon skipping and dystrophin restoration in in vitro models of duchenne muscular dystrophy
A López-Martínez, P Soblechero-Martín, V Arechavala-Gomeza
Antisense RNA Design, Delivery, and Analysis, 217-233, 2022
42022
A CRISPR/Cas9-Based Approach For Editing Immortalised Human Myoblasts To Model Duchenne Muscular Dystrophy In Vitro
P Soblechero-Martín, E Albiasu-Arteta, A Anton-Martinez, ...
bioRxiv, 2020.02. 24.962316, 2020
12020
Deletion of exons 45 to 55 in the DMD gene: from the therapeutic perspective to the in vitro model
J Poyatos-Garcia, P Soblechero-Martin, A Liquori, A Lopez-Martinez, ...
bioRxiv, 2023.09. 13.557649, 2023
2023
VP. 88 Characterisation of cell culture models of myotonic dystrophy type I by In-Cell Western technology and digital droplet PCR
A López-Martínez, P Soblechero-Martín, C Catalli, A Jauregui-Barrutia, ...
Neuromuscular Disorders 32, S132-S133, 2022
2022
Lessons learned from developing an oligonucleotide drug for a rare disease
P Soblechero-Martín, V Arechavala-Gomeza
RNA Therapeutics, 121-137, 2022
2022
DMD-BIOMARKERS: EP. 161 A novel cell-based screening assay for the identification of utrophin-upregulating compounds
P Soblechero-Martín, A López-Martínez, V Arechavala-Gomeza
Neuromuscular Disorders 31, S98, 2021
2021
A CRISPR/Cas9 edition protocol for human myoblasts to generate disease models
P Soblechero-Martin, E Albiasu-Arteta, A Anton-Martinez, ...
HUMAN GENE THERAPY 30 (11), A189-A189, 2019
2019
P. 290Dystrophinopathic subjects with a specific mega-deletion of exons 45-55 in the DMD gene, as a template for CRISPR/Cas9 therapy in Duchenne muscular dystrophy
J Poyatos-García, P Soblechero-Martín, E Albiasu-Arteta, ...
Neuromuscular Disorders 29, S151-S152, 2019
2019
P. 291Overcoming barriers to establish a CRISPR/Cas9 edition protocol for human myoblasts
P Soblechero-Martin, E Albiasu-Arteta, J Poyatos-García, ...
Neuromuscular Disorders 29, S152, 2019
2019
Cómo mejorar la distribución de los medicamentos antisentido para acelerar su tránsito a la clínica
P Soblechero-Martín, V Arechavala-Gomeza
Genética Médica News 3 (3), 23-25, 2019
2019
916 Murine model for the evaluation of hyperoxaluria on metabolic syndrome patients
J Saenz, E Jorge, C Corbacho, M Santos, A Sanchez, P Soblechero, ...
European Urology Supplements 3 (15), e916, e916a, 2016
2016
Comments on “Hipercarotinemia after bariatric surgery”
PS Martin, FG Lorencio, ED Navarro, MR de los Ángeles Silvestre
Endocrinolog ay Nutrici n (English Edition) 7 (63), 374-375, 2016
2016
Comentarios sobre «Hipercarotinemia tras cirugía bariátrica»
P Soblechero Martin, F Granado Lorencio, E Donoso Navarro, ...
Endocrinología y Nutrición 63 (7), 374-375, 2016
2016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–19